Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Mountain Crest Acquisition Corp II
Diabetes DTx startup Better Therapeutics heads to public markets in SPAC deal
By
Mallory Hackett
|
01:01 pm |
April 07, 2021
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.